Search studies using keywords
325 Studies contain the keyword metabolic (showing 201-220)
Pages: << 11 12 13 14 15 16 17
No data sets (in No Studies) added to Browser
Identifier Name Phenotype(s) Total p-values Related citationsAdd data sets to Browser Related data
HGVST1603 plus GWAS of Beta-2 microglubulin plasma levels 
  • Beta-2 microglubulin plasma levels
7
HGVST1593 plus GWAS of Refractive error 
  • Refractive error
26
HGVST1568 plus GWAS of Oleic acid (18:1n-9) plasma levels 
  • Oleic acid (18:1n-9) plasma levels
  • Palmitoleic acid (16:1n-7) plasma levels
  • Palmitic acid (16:0) plasma levels
  • Stearic acid (18:0) plasma levels
47
HGVST1563 plus GWAS of Iron deficiency 
  • Iron status biomarkers (Total iorn-binding capacity)
  • Iron status biomarkers (Total iron-binding capacity)
  • Iron status biomarkers (Transferrin saturation)
  • Iron status biomarkers (Body iron)
  • Iron status biomarkers (Serum ferritin concentration)
  • Iron status biomarkers (Unsaturated iron-binding capacity)
  • Iron deficiency (Case-control)
10
HGVST1559 plus GWAS of Alcohol dependence 
  • Alcohol dependence
1
HGVST1560 plus GWAS of Type 2 diabetes (dietary heme iron intake interaction) 
  • Type 2 diabetes (dietary heme iron intake interaction)
4
HGVST1551 plus GWAS of Dietary macronutrient intake 
  • Dietary macronutrient intake (Protein - model 2)
  • Dietary macronutrient intake (Carbohydrates - model 2)
3
HGVST1547 plus GWAS of Thyroid hormone levels 
  • Thyroid hormone levels (FT4)
  • Thyroid hormone levels (TSH)
  • Thyroid hormone levels (FT4-Males)
  • Thyroid hormone levels (TSH - Males)
  • Thyroid hormone levels (FT4-Females)
  • Thyroid hormone levels (TSH - Females)
60
HGVST1538 plus GWAS of Longevity 
  • Longevity
1
HGVST1528 plus GWAS of Thiazide-induced adverse metabolic effects in hypertensive patients 
  • Thiazide-induced adverse metabolic effects in hypertensive patients (AA-triglyceride response)
  • Thiazide-induced adverse metabolic effects in hypertensive patients (EA-triglyceride response)
  • Thiazide-induced adverse metabolic effects in hypertensive patients (EA-glucose response)
  • Thiazide-induced adverse metabolic effects in hypertensive patients (AA-glucose response)
59
HGVST1516 plus GWAS of Systemic lupus erythematosus 
  • Systemic lupus erythematosus
5
HGVST1511 plus GWAS of Response to fenofibrate (adiponectin levels) 
  • Response to fenofibrate (adiponectin levels) (Response)
  • Response to fenofibrate (adiponectin levels) (Baseline)
12
HGVST1480 plus GWAS of Beta-trace protein levels 
  • Beta-trace protein levels (EA)
1
HGVST1481 plus GWAS of Metabolite levels (5-HIAA) 
  • Metabolite levels (MHPG)
  • Metabolite levels (HVA/5-HIAA ratio)
  • Metabolite levels (5-HIAA/ MHPG Ratio)
  • Metabolite levels (HVA/MHPG ratio)
  • Metabolite levels (HVA)
  • Metabolite levels (HVA-5-HIAA Factor score)
  • Metabolite levels (5-HIAA)
96
HGVST1474 plus GWAS of Gout 
  • Urate levels (candidate)
  • Urate levels (women)
  • Urate levels
  • Urate levels (network)
  • Gout
52
HGVST1475 plus GWAS of Smoking behavior 
  • Smoking behavior
3
HGVST1473 plus GWAS of Metabolite levels 
  • Metabolite levels (Glycerolphosphocholine)
  • Metabolite levels (2,6 dimethylheptanoyl carnitine)
  • Metabolite levels (Caprolactam)
  • Metabolite levels (Unknown)
  • Metabolite levels (Glycochenodeoxycholic acid 3-glucuronide)
  • Metabolite levels (Bilirubin)
  • Metabolite levels (C9H14Ona)
  • Metabolite levels (Glycerophospho-N-Palmitoyl Ethanolamine)
9
HGVST1458 plus GWAS of Body mass (lean) 
  • Body mass (lean) (ALM-ABS)
1
HGVST1438 plus GWAS of Comprehensive strength and appendicular lean mass 
  • Comprehensive strength and appendicular lean mass (Males)
  • Comprehensive strength and appendicular lean mass (Males + Females)
2
HGVST1421 plus GWAS of Capecitabine sensitivity 
  • Capecitabine sensitivity
  • Capecitabine sensitivity (European ancestry)
22